AADI News and Press, Aadi Bioscience Inc. From 09/05/23

Aadi Bioscience to Participate at Upcoming Investor Conferences PR Newswire LOS ANGELES , Sept. 5, 2023 /PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for genetically...

2023-08-09 11:30:30 ET Aadi Bioscience, Inc. (AADI) Q2 2023 Earnings Conference Call August 9, 2023, 08:30 AM ET Company Participants Marcy Graham - SVP of IR and Corporate Communications Scott Giacobello - Interim CEO, President, and CFO Loretta Itri - Chief Med...

2023-08-09 08:06:37 ET Aadi Bioscience press release ( NASDAQ: AADI ): Q2 GAAP EPS of -$0.67 misses by $0.07 . Revenue of $6.2M (+80.2% Y/Y) misses by $0.11M . Cash, cash equivalents and short-term investments as of June 30, 2023, were $134.9 million as compare...

Aadi Bioscience Announces Financial Results for the Second Quarter 2023 and Provides Corporate Update PR Newswire Continued growth in total revenue on FYARRO® with sales of $6.2 million for 2Q 2023 On-track for interim analysis on 40 patients in PRECISION1 tri...

2023-08-08 13:56:56 ET Aadi Bioscience ( NASDAQ: AADI ) is scheduled to announce Q2 earnings results on Wednesday, August 9th, before market open. The consensus EPS Estimate is -$0.60 (+31.0% Y/Y) and the consensus Revenue Estimate is $6.31M (+84.0% Y/Y).Over the last 3 mont...

Aadi Bioscience to Report Second Quarter 2023 Results and Operational Update PR Newswire Company to Host Conference Call and Webcast on Wednesday, August 9, 2023 LOS ANGELES , Aug. 2, 2023 /PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a c...

2023-06-29 18:10:40 ET Summary Today, we take our first look at a small cap oncology name called Aadi Bioscience, Inc. The firm's main asset is a product called FYARRO which is approved for one rare indication and is being evaluated for additional tumor types. An investment an...

Aadi Bioscience Announces Presentations at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting PR Newswire LOS ANGELES , May 25, 2023 /PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on de...

Aadi Bioscience to Participate in Upcoming Investor Events PR Newswire LOS ANGELES , May 23, 2023 /PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision therapies for genetica...

2023-05-10 11:33:02 ET Aadi Bioscience, Inc. (AADI) Q1 2023 Earnings Conference Call May 10, 2023, 08:30 AM ET Company Participants Marcy Graham - Senior Vice President of Investor Relations and Corporate Communications Neil Desai - Founder and Executive Chairman ...